Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
C. Nelson Hayes & Kazuaki Chayama. (2017) Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV. Expert Review of Clinical Pharmacology 10:6, pages 583-594.
Read now
Read now
Piyachat Roopngam, Kewei Liu, Lin Mei, Yi Zheng, Xianbing Zhu, Hsiang-I Tsai & Laiqiang Huang. (2016) Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-co-glycolide microspheres could induce mice cytotoxic T-cell response. International Journal of Nanomedicine 11, pages 5361-5370.
Read now
Read now
Catherine Fauvelle, Che C. Colpitts, Zhen-yong Keck, Brian G. Pierce, Steven K. H. Foung & Thomas F. Baumert. (2016) Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies. Expert Review of Vaccines 15:12, pages 1535-1544.
Read now
Read now
Saloume Mehrlatifan, Seyyedeh Masumeh Mirnurollahi, Fatemeh Motevalli, Pooneh Rahimi, Sepehr Soleymani & Azam Bolhassani. (2016) The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model. Drug Delivery 23:8, pages 2852-2859.
Read now
Read now
Karim M Abdel-Hady, Andres H Gutierrez, Frances Terry, Joe Desrosiers, Anne S De Groot & Hassan ME Azzazy. (2014) Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome. Human Vaccines & Immunotherapeutics 10:8, pages 2366-2377.
Read now
Read now
Bharti Mehta, Vijay Kumar Dharma, Sumit Chawla, Harashish Jindal & Bhumika Bhatt. (2014) Hepatitis C. Human Vaccines & Immunotherapeutics 10:2, pages 417-419.
Read now
Read now
Ayssa A. Self, Phyllis T. Losikoff & Stephen H. Gregory. (2013) Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C. Human Vaccines & Immunotherapeutics 9:7, pages 1569-1576.
Read now
Read now
Bertrand Bellier & David Klatzmann. (2013) Virus-like particle-based vaccines against hepatitis C virus infection. Expert Review of Vaccines 12:2, pages 143-154.
Read now
Read now
Mélanie Lambotin, Heidi Barth, Christiane Moog, François Habersetzer, Thomas F Baumert, Françoise Stoll-Keller & Samira Fafi-Kremer. (2012) Challenges for HCV vaccine development in HIV–HCV coinfection. Expert Review of Vaccines 11:7, pages 791-804.
Read now
Read now
Liz Alvarez-Lajonchere & Santiago Dueñas-Carrera. (2012) Complete Definition of Immunological Correlates of Protection and Clearance of Hepatitis C Virus Infection: A Relevant Pending Task for Vaccine Development. International Reviews of Immunology 31:3, pages 223-242.
Read now
Read now
Eleanor Barnes & Andrew J Pollard. (2011) Vaccines in clinical trials: infectious disease. Expert Review of Vaccines 10:5, pages 555-557.
Read now
Read now
Articles from other publishers (73)
Hardeep Kaur, Virender Kumar, Rakesh Kumar Marwaha, Gajendra Singh & Davinder Kumar. 2023. Nanovaccinology. Nanovaccinology
331
342
.
Lorenza Di Marco, Claudia La Mantia & Vito Di Marco. (2022) Hepatitis C: Standard of Treatment and What to Do for Global Elimination. Viruses 14:3, pages 505.
Crossref
Crossref
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno & Juan Cristina. (2021) In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?. World Journal of Hepatology 13:10, pages 1234-1268.
Crossref
Crossref
Elodie Laugel, Cédric Hartard, Hélène Jeulin, Sibel Berger, Véronique Venard, Jean‐Pierre Bronowicki & Evelyne Schvoerer. (2020) Full‐length genome sequencing of RNA viruses—How the approach can enlighten us on hepatitis C and hepatitis E viruses. Reviews in Medical Virology 31:4.
Crossref
Crossref
Vanessa M. Cowton, Ania M. Owsianka, Valeria Fadda, Ana Maria Ortega-Prieto, Sarah J. Cole, Jane A. Potter, Jessica K. Skelton, Nathan Jeffrey, Caterina Di Lorenzo, Marcus Dorner, Garry L. Taylor & Arvind H. Patel. (2021) Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design. npj Vaccines 6:1.
Crossref
Crossref
MunaR Ahmed & WarqaaY Salih. (2021) Detection of Hepatitis C Virus Genotype 1a among Patients from Al-Nasiriya City and Determining its Transmission Risk Factors. Iraqi Journal of Community Medicine 34:1, pages 27.
Crossref
Crossref
Bin Nie, Yongcan Guo, Kaijiong Zhang, Jinbo Liu & Sunguang Yun. (2020) Analysis of drug-resistance-associated mutations and genetic barriers in hepatitis C virus NS5B sequences in China. Archives of Virology 165:9, pages 2013-2020.
Crossref
Crossref
Jason Gummow, Makutiro G. Masavuli, Zelalem A. Mekonnen, Yanrui Li, Danushka K. Wijesundara, Ashish C. Shrestha, Ilia Voskoboinik, Eric J. Gowans & Branka Grubor-Bauk. (2020) Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus. Vaccines 8:1, pages 53.
Crossref
Crossref
Sonali Kochhar, Jean-Louis Excler, Karin Bok, Marc Gurwith, Michael M. McNeil, Stephen J. Seligman, Najwa Khuri-Bulos, Bettina Klug, Marian Laderoute, James S. Robertson, Vidisha Singh & Robert T. Chen. (2019) Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines. Vaccine 37:38, pages 5796-5802.
Crossref
Crossref
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi & Navid Nezafat. (2018) Designing a Fusion Protein Vaccine Against HCV: An In Silico Approach. International Journal of Peptide Research and Therapeutics 25:3, pages 861-872.
Crossref
Crossref
Yu Yang, Zheng-Kun Tu, Xing-Kai Liu & Ping Zhang. (2018) Mononuclear phagocyte system in hepatitis C virus infection. World Journal of Gastroenterology 24:44, pages 4962-4973.
Crossref
Crossref
Gregory R Hart & Andrew L Ferguson. (2018) Computational design of hepatitis C virus immunogens from host-pathogen dynamics over empirical viral fitness landscapes. Physical Biology 16:1, pages 016004.
Crossref
Crossref
Divya Khanna, Vikas Kaushik & Atul Kumar Upadhyay. (2018) Genome-wide prediction and analysis of siRNA as potential antiviral agent against Hepatitis-C virus. Genome-wide prediction and analysis of siRNA as potential antiviral agent against Hepatitis-C virus.
K. G. Young, K. Haq, S. MacLean, R. Dudani, S. M. Elahi, R. Gilbert, R. D. Weeratna & L. Krishnan. (2018) Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens. Journal of Viral Hepatitis 25:6, pages 649-660.
Crossref
Crossref
Xuan Guo, Jin-Yi Zhong & Jun-Wen Li. (2018) Hepatitis C Virus Infection and Vaccine Development. Journal of Clinical and Experimental Hepatology 8:2, pages 195-204.
Crossref
Crossref
Radhika Gopal, Kelli Jackson, Netanel Tzarum, Leopold Kong, Andrew Ettenger, Johnathan Guest, Jennifer M. Pfaff, Trevor Barnes, Andrew Honda, Erick Giang, Edgar Davidson, Ian A. Wilson, Benjamin J. Doranz & Mansun Law. (2017) Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis. PLOS Pathogens 13:12, pages e1006735.
Crossref
Crossref
Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Joseph Torresi, Eric J. Gowans & Branka Grubor-Bauk. (2017) Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C. Frontiers in Microbiology 8.
Crossref
Crossref
Laure Stella Ghoma Linguissi & Celine Nguefeu Nkenfou. (2017) Epidemiology of viral hepatitis in the Republic of Congo: review. BMC Research Notes 10:1.
Crossref
Crossref
Reza Taherkhani & Fatemeh Farshadpour. (2017) Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World Journal of Hepatology 9:33, pages 1239-1252.
Crossref
Crossref
Brian G. Pierce, Elisabeth N. Boucher, Kurt H. Piepenbrink, Monir Ejemel, Chelsea A. Rapp, William D. ThomasJr.Jr., Eric J. Sundberg, Zhiping Weng & Yang Wang. (2017) Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope. Journal of Virology 91:20.
Crossref
Crossref
Sayed F. Abdelwahab. (2016) Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?. Infectious Agents and Cancer 11:1.
Crossref
Crossref
Lan S. Wang, Lionel S. D'Souza & Ira M. Jacobson. (2016) Hepatitis C-A clinical review. Journal of Medical Virology 88:11, pages 1844-1855.
Crossref
Crossref
Bo Hu, Shanshan Li, Zhanfeng Zhang, Shenggao Xie, Yuqian Hu, Xianzhang Huang & Yi Zheng. (2016) HCV NS4B targets Scribble for proteasome-mediated degradation to facilitate cell transformation. Tumor Biology 37:9, pages 12387-12396.
Crossref
Crossref
Dimas Alexandre Kliemann, Cristiane Valle Tovo, Ana Beatriz Gorini da Veiga, André Luiz Machado & John West. (2016) Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank. PLOS ONE 11:8, pages e0159924.
Crossref
Crossref
Leo Swadling, John Halliday, Christabel Kelly, Anthony Brown, Stefania Capone, M. Ansari, David Bonsall, Rachel Richardson, Felicity Hartnell, Jane Collier, Virginia Ammendola, Mariarosaria Del Sorbo, Annette Von Delft, Cinzia Traboni, Adrian Hill, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Paul Klenerman, Antonella Folgori & Eleanor Barnes. (2016) Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines 4:3, pages 27.
Crossref
Crossref
G. Martínez-Donato, B. Piniella, D. Aguilar, S. Olivera, A. Pérez, Y. Castañedo, L. Alvarez-Lajonchere, S. Dueñas-Carrera, J. W. Lee, N. Burr, M. Gonzalez-Miro & B. H. A. Rehm. (2016) Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System. Clinical and Vaccine Immunology 23:4, pages 370-378.
Crossref
Crossref
Mohamed A Daw, Abdallah El-Bouzedi & Aghnaya A Dau. (2015) Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission. BMC Research Notes 8:1.
Crossref
Crossref
Gregory R Hart & Andrew L Ferguson. (2015) Empirical fitness models for hepatitis C virus immunogen design. Physical Biology 12:6, pages 066006.
Crossref
Crossref
Sara Mohammadzadeh, Farzin Roohvand, Soheila Ajdary, Parastoo Ehsani & Ali Hatef Salmanian. (2015) Heterologous Expression of Hepatitis C Virus Core Protein in Oil Seeds of Brassica napus L.. Jundishapur Journal of Microbiology 8:11.
Crossref
Crossref
Faisal Nouroz, Sidra Shaheen, Ghulam Mujtaba & Shumaila Noreen. (2015) An overview on hepatitis C virus genotypes and its control. Egyptian Journal of Medical Human Genetics 16:4, pages 291-298.
Crossref
Crossref
María Soledad Llanes, Natalia Soledad Palacios, Magalí Piccione, María Guillermina Ruiz & Carla Layana. (2015) Aspectos moleculares de la respuesta antiviral contra el virus de la hepatitis C importantes para el desarrollo de vacunas. Enfermedades Infecciosas y Microbiología Clínica 33:4, pages 273-280.
Crossref
Crossref
Daniel P Webster, Paul Klenerman & Geoffrey M Dusheiko. (2015) Hepatitis C. The Lancet 385:9973, pages 1124-1135.
Crossref
Crossref
Leon L Seifert. (2015) Update on hepatitis C: Direct-acting antivirals. World Journal of Hepatology 7:28, pages 2829.
Crossref
Crossref
QINGFENG SONG, CHANG ZHAO, SHENGQIU OU, ZHIBIN MENG, PING KANG, LIWEI FAN, FENG QI & YILONG MA. (2015) Co-expression analysis of differentially expressed genes in hepatitis C virus-induced hepatocellular carcinoma. Molecular Medicine Reports 11:1, pages 21-28.
Crossref
Crossref
Faezeh Ghasemi. (2015) Progress in the development of vaccines for hepatitis C virus infection. World Journal of Gastroenterology 21:42, pages 11984.
Crossref
Crossref
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, A. V. Ivanov, V. L. Tunitskaya & A. A. Kushch. (2015) Enhancement of the immune response by codelivery of hepatitis C virus recombinant DNA and proteins of the replicative complex. Molecular Genetics, Microbiology and Virology 30:1, pages 39-47.
Crossref
Crossref
Aintzane Zabaleta, Delia D'Avola, Itziar Echeverria, Diana Llopiz, Leyre Silva, Lorea Villanueva, José Ignacio Riezu-Boj, Esther Larrea, Alexander Pereboev, Juan José Lasarte, Iago Rodriguez-Lago, Mercedes Iñarrairaegui, Bruno Sangro, Jesús Prieto & Pablo Sarobe. (2015) Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Molecular Therapy - Methods & Clinical Development 2, pages 15006.
Crossref
Crossref
Hila Shalom-Elazari, Hadas Zazrin-Greenspon, Hadassa Shaked & Jordan H. Chill. (2014) Global fold and backbone dynamics of the hepatitis C virus E2 glycoprotein transmembrane domain determined by NMR. Biochimica et Biophysica Acta (BBA) - Biomembranes 1838:11, pages 2919-2928.
Crossref
Crossref
Daylen Aguilar-Noriega, Liz Alvarez-Lajonchere, Emma Brown, Felix Leonardo Santana, Jean Dubuisson, Czeslaw Wychowski, Ivis Guerra, Gillian Martínez-Donato, Angel Pérez, Yalena Amador-Cañizares & Santiago Dueñas-Carrera. (2014) A chimeric protein encompassing hepatitis C virus epitopes is able to elicit both humoral and cell-mediated immune responses in mice. Biotechnology and Applied Biochemistry 61:6, pages 627-636.
Crossref
Crossref
Jorjoh Ndure & Katie L. Flanagan. (2014) Targeting regulatory T cells to improve vaccine immunogenicity in early life. Frontiers in Microbiology 5.
Crossref
Crossref
Bethany White, Annie Madden, Maria Prins, Margaret Hellard, Handan Wand, Gregory J. Dore, Kimberly Page & Lisa Maher. (2014) Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study. Vaccine 32:42, pages 5460-5467.
Crossref
Crossref
Christine Hartoonian, Zargham Sepehrizadeh, Mehdi Mahdavi, Arash Arashkia, Yon Suk Jang, Maasoumeh Ebtekar, Mojtaba Tabatabai Yazdi, Babak Negahdari, Azita Nikoo & Kayhan Azadmanesh. (2014) Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant. Molecular Biology Reports 41:9, pages 5943-5952.
Crossref
Crossref
Sasmita Mishra, Bianca J. Lavelle, Joe Desrosiers, Matt T. Ardito, Frances Terry, William D. Martin, Anne S. De Groot & Stephen H. Gregory. (2014) Dendritic Cell-Mediated, DNA-Based Vaccination against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice. PLoS ONE 9:8, pages e104606.
Crossref
Crossref
Muhammad Waqar, Asad Ullah Khan, Amjad Ali, Muhammad Wasim, Muhammad Idrees, Zobia Ismail, Agha Asad Noor, Noorul Akbar, Shaista Bano, Muhammad Arif Khan & Rahim Ullah Khan. (2014) Prevalence and Molecular Determination of Hepatitis C Infection in Khyber Pakhtunkhwa, Pakistan. Archives of Clinical Infectious Diseases 9:3.
Crossref
Crossref
Ahmed A. Quadeer, Raymond H. Y. Louie, Karthik Shekhar, Arup K. Chakraborty, I-Ming Hsing & Matthew R. McKay. (2014) Statistical Linkage Analysis of Substitutions in Patient-Derived Sequences of Genotype 1a Hepatitis C Virus Nonstructural Protein 3 Exposes Targets for Immunogen Design. Journal of Virology 88:13, pages 7628-7644.
Crossref
Crossref
A. A. Quadeer, R. H. Y. Louie, K. Shekhar, A. K. Chakraborty, I. Hsing & M. R. McKay. (2014) Discovering statistical vulnerabilities in highly mutable viruses: A random matrix approach. Discovering statistical vulnerabilities in highly mutable viruses: A random matrix approach.
Sasmita Mishra, Phyllis T. Losikoff, Alyssa A. Self, Frances Terry, Matthew T. Ardito, Ryan Tassone, William D. Martin, Anne S. De Groot & Stephen H. Gregory. (2014) Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells. Vaccine 32:26, pages 3285-3292.
Crossref
Crossref
Nabeen C. Nayak. (2014) Cirrhosis and end-stage chronic liver disease: The changing scenes on etiopathogenesis. Current Medicine Research and Practice 4:2, pages 62-77.
Crossref
Crossref
Zhong Zhao, Lilin Zhong, Elizabeth Elrod, Evi Struble, Li Ma, Hailing Yan, Christine Harman, Lu Deng, Maria Luisa Virata-Theimer, Peter Liu, Harvey Alter, Arash Grakoui & Pei Zhang. (2014) A Neutralization Epitope in the Hepatitis C Virus E2 Glycoprotein Interacts with Host Entry Factor CD81. PLoS ONE 9:1, pages e84346.
Crossref
Crossref
M. Estée Török. 2014. Manson's Tropical Infectious Diseases. Manson's Tropical Infectious Diseases
112
128.e1
.
Rachel Sacks-Davis, Campbell K. Aitken, Peter Higgs, Tim Spelman, Alisa E. Pedrana, Scott Bowden, Mandvi Bharadwaj, Usha K. Nivarthi, Vijayaprakash Suppiah, Jacob George, Jason Grebely, Heidi E. Drummer & Margaret Hellard. (2013) High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study. PLoS ONE 8:11, pages e80216.
Crossref
Crossref
Muriel Lavie & Jean Dubuisson. (2013) Structural knowledge of HCV envelope protein region recognized by broadly neutralizing antibodies. Future Virology 8:10, pages 949-952.
Crossref
Crossref
Anne Fournillier, Lars Frelin, Emilie Jacquier, Gustaf Ahlén, Anette Brass, Estelle Gerossier, Fredrik Holmström, Kate E. Broderick, Niranjan Y. Sardesai, Jean-Yves Bonnefoy, Geneviève Inchauspé & Matti Sällberg. (2013) A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus. The Journal of Infectious Diseases 208:6, pages 1008-1019.
Crossref
Crossref
Bo Wen, Yao Deng, Hong Chen, Jie Guan, Xia Chuai, Li Ruan, Wei Kong & Wenjie Tan. (2013) The Novel Replication-defective Vaccinia Virus (Tiantan Strain)–based Hepatitis C Virus Vaccine Induces Robust Immunity in Macaques. Molecular Therapy 21:9, pages 1787-1795.
Crossref
Crossref
Daisuke Akazawa, Masaki Moriyama, Hiroshi Yokokawa, Noriaki Omi, Noriyuki Watanabe, Tomoko Date, Kenichi Morikawa, Hideki Aizaki, Koji Ishii, Takanobu Kato, Hidenori Mochizuki, Noriko Nakamura & Takaji Wakita. (2013) Neutralizing Antibodies Induced by Cell Culture–Derived Hepatitis C Virus Protect Against Infection in Mice. Gastroenterology 145:2, pages 447-455.e4.
Crossref
Crossref
Carmen E. Gómez, Beatriz Perdiguero, María Victoria Cepeda, Lidia Mingorance, Juan García-Arriaza, Andrea Vandermeeren, Carlos Óscar S. Sorzano & Mariano Esteban. (2013) High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome. Journal of Virology 87:13, pages 7282-7300.
Crossref
Crossref
Bethany White, Annie Madden, Margaret Hellard, Thomas Kerr, Maria Prins, Kimberly Page, Gregory J. Dore & Lisa Maher. (2013) Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. Drug and Alcohol Review 32:4, pages 419-425.
Crossref
Crossref
Catherine Fauvelle, Quentin Lepiller, Daniel J. Felmlee, Isabel Fofana, François Habersetzer, Françoise Stoll-Keller, Thomas F. Baumert & Samira Fafi-Kremer. (2013) Hepatitis C virus vaccines – Progress and perspectives. Microbial Pathogenesis 58, pages 66-72.
Crossref
Crossref
Yao Deng, Jie Guan, Bo Wen, Na Zhu, Hong Chen, Jindong Song, Yang Yang, Yue Wang & Wenjie Tan. (2013) Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles. PLoS ONE 8:4, pages e62684.
Crossref
Crossref
Kimberly Page, William Osburn, Jennifer Evans, Judith A. Hahn, Paula Lum, Alice Asher, Eric Delwart, Leslie Tobler, Andrea L. Cox & Michael P. Busch. (2013) Frequent Longitudinal Sampling of Hepatitis C Virus Infection in Injection Drug Users Reveals Intermittently Detectable Viremia and Reinfection. Clinical Infectious Diseases 56:3, pages 405-413.
Crossref
Crossref
Mirjam B. Zeisel, Daniel J. Felmlee & Thomas F. Baumert. 2013. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy
87
112
.
Jorge Reyes-del Valle, Cynthia de la Fuente, Mallory A. Turner, Christoph Springfeld, Swapna Apte-Sengupta, Marie E. Frenzke, Amelie Forest, Jillian Whidby, Joseph Marcotrigiano, Charles M. Rice & Roberto Cattaneo. (2012) Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster. Journal of Virology 86:21, pages 11558-11566.
Crossref
Crossref
Su–Hyung Park, Eui–Cheol Shin, Stefania Capone, Laura Caggiari, Valli De Re, Alfredo Nicosia, Antonella Folgori & Barbara Rehermann. (2012) Successful Vaccination Induces Multifunctional Memory T-Cell Precursors Associated With Early Control of Hepatitis C Virus. Gastroenterology 143:4, pages 1048-1060.e4.
Crossref
Crossref
PD Griffiths. (2012) Wish list for viral vaccinologists. Reviews in Medical Virology 22:5, pages 281-284.
Crossref
Crossref
Lynn B. Dustin. (2012) Too low to measure, infectious nonetheless. Blood 119:26, pages 6181-6182.
Crossref
Crossref
Leopold KongErick GiangJustin B. RobbinsRobyn L. StanfieldDennis R. Burton, Ian A. Wilson & Mansun Law. (2012) Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proceedings of the National Academy of Sciences 109:24, pages 9499-9504.
Crossref
Crossref
Ying Hu, Chuanhua Yu, Banghua Chen & Lei Wang. (2012) Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004–2010. Journal of Huazhong University of Science and Technology [Medical Sciences] 32:3, pages 428-433.
Crossref
Crossref
Benoît Callendret & Christopher M. Walker. (2012) Will There Be a Vaccine to Protect Against the Hepatitis C Virus?. Gastroenterology 142:6, pages 1384-1387.
Crossref
Crossref
Jason Grebely, Maria Prins, Margaret Hellard, Andrea L Cox, William O Osburn, Georg Lauer, Kimberly Page, Andrew R Lloyd & Gregory J Dore. (2012) Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. The Lancet Infectious Diseases 12:5, pages 408-414.
Crossref
Crossref
Sarah C. Gilbert. (2011) T‐cell‐inducing vaccines – what’s the future. Immunology 135:1, pages 19-26.
Crossref
Crossref
Esther D. Quakkelaar & Cornelis J.M. Melief. 2012. Synthetic Vaccines. Synthetic Vaccines
77
106
.
Natalie A. Parlane, Katrin Grage, Jason W. Lee, Bryce M. Buddle, Michel Denis & Bernd H. A. Rehm. (2011) Production of a Particulate Hepatitis C Vaccine Candidate by an Engineered Lactococcus lactis Strain. Applied and Environmental Microbiology 77:24, pages 8516-8522.
Crossref
Crossref
J. M. Marrazzo & W. Cates. (2011) Interventions to Prevent Sexually Transmitted Infections, Including HIV Infection. Clinical Infectious Diseases 53:suppl 3, pages S64-S78.
Crossref
Crossref